Cancer Pain

• CLINICAL_TRIALS trial_result · 2012-01-25
  Clinical Trial Update: Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids [Phase 3]

  Phase 3 efficacy and safety study of Nasalfent (fentanyl citrate nasal spray) for breakthrough cancer pain in patients taking regular opioid…

• FDA approval · 2012-01-25
  FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (Genus Lifesciences Inc.)

  FDA approved a supplemental application for oxycodone hydrochloride filed by Genus Lifesciences Inc.

• FDA approval · 2011-07-15
  FDA Approved: MORPHINE SULFATE — Original Application (SpecGx LLC)

  FDA approved the Original Application for Morphine Sulfate from SpecGx LLC, granting a generic version market authorization and confirming i…

• CLINICAL_TRIALS trial_result · 2011-05-19
  Clinical Trial Update: Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]

  A Phase 3 trial update on the safety and clinical use of the Fentanyl Transdermal System for cancer-related pain, with the study status mark…

• CLINICAL_TRIALS trial_result · 2011-05-19
  Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs). [Phase 4]

  This Phase 4 trial compared fentanyl transdermal system to weak opioids in patients with moderate to severe chronic cancer pain who had prev…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2011-05-17
  Clinical Trial Update: Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain [Phase 4]

  Phase 4 trial evaluating the efficacy and safety of a fentanyl transdermal patch for chronic cancer pain was terminated.

• CLINICAL_TRIALS trial_result · 2011-05-04
  Clinical Trial Update: Ketamine Associated With Opioids in Refractory Cancer Pain Treatment [Phase 3]

  This document reports a Phase 3 clinical trial evaluating the use of ketamine in combination with opioids for refractory cancer pain, and no…

• CLINICAL_TRIALS trial_result · 2011-03-29
  Clinical Trial Update: Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain [Phase 2]

  Phase 2 clinical trial evaluating caffeine injection as an adjuvant to opioid therapy for cancer-related pain; results were posted after com…

• FDA approval · 2011-02-09
  FDA Approved: FENTANYL TRANSDERMAL — Original Application (SpecGx LLC)

  FDA approved a fentanyl transdermal patch as a generic product under an Original Application (ANDA 077154) for use in opioid-tolerant adults…

• CLINICAL_TRIALS trial_result · 2011-01-24
  Clinical Trial Update: Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics - [Phase 2]

  A Phase II trial evaluating the effectiveness, safety, and pharmacokinetics of a fentanyl transdermal matrix patch for cancer-related pain; …

• CLINICAL_TRIALS trial_result · 2010-04-27
  Clinical Trial Update: A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients. [Phase 3]

  Phase 3 clinical trial comparing OROS hydromorphone hydrochloride with morphine for cancer-related pain has completed.

• FDA approval · 2010-04-05
  FDA Approved: OXYCONTIN — Original Application (Purdue Pharma LP)

  The FDA approved the original application for OxyContin (oxycodone hydrochloride) by Purdue Pharma LP for relief of moderate to severe pain.

• CLINICAL_TRIALS trial_result · 2010-02-05
  Clinical Trial Update: Fentanyl Matrix in Lung Cancer Pain [Phase 4]

  Phase 4 trial update indicating completion of a fentanyl matrix (fentanyl patch) study for lung cancer-related pain; no results are reported…

• FDA approval · 2009-11-09
  FDA Approved: FENTANYL CITRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA has approved a supplemental application for fentanyl citrate by Teva Pharmaceuticals USA, Inc., marking an approved modification to …

• CLINICAL_TRIALS trial_result · 2009-03-10
  Clinical Trial Update: Palliative Radiotherapy for Bone Metastases: Single Versus Multiple Fractions. [Phase 3]

  This update reports the completion of a Phase 3 trial comparing single-fraction versus multiple-fraction palliative radiotherapy for bone me…

• FDA approval · 2008-03-17
  FDA Approved: MORPHINE SULFATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved Morphine Sulfate under Hikma Pharmaceuticals USA Inc.'s Original Application (NDA 022195), authorizing the marketing of thi…

• FDA approval · 2007-01-23
  FDA Approved: FENTANYL — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA has approved a supplemental application for a fentanyl generic product from Mylan Pharmaceuticals Inc.